𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of recombinant factor VIIa during orthotopic liver transplantation

✍ Scribed by Andrea De Gasperi; Francesco Baudo

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
46 KB
Volume
12
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of repeated perioper
Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation
✍ J. Peter A. Lodge; Sven Jonas; Robert M. Jones; Michael Olausson; JosΓ© Mir-Palla πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

## Patients undergoing orthotopic liver transplantation (OLT) have excessive blood loss during surgery that requires blood transfusions, leading to increased postoperative morbidity and mortality. We studied the efficacy and safety of activated recombinant factor VII (rFVIIa) in reducing transfusio

Systemic release of interleukin-10 durin
Systemic release of interleukin-10 during orthotopic liver transplantation
✍ Olivier Le Moine; Arnaud Marchhant; FranΓ§ois Durand; Brigitte Ickx; Olrvier Prad πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 420 KB

Experimental and clinical observations indicate that the liver allograft is less immunogenic than other organ transplants and can promote immune tolerance. Because interleukin-10 recently emerged as a macrophage and T-cell-derived cytokine with potent immunosuppressive properties, we studied its pro

Safety and efficacy of a single bolus ad
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease
✍ Raymond M. Planinsic; Jan van der Meer; Giuliano Testa; Luis Grande; Angel Cande πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views

Orthotopic liver transplantation (OLT) can be associated with excessive blood loss. As a result, there may be increased risk of adverse outcomes. Activated recombinant factor VII (rFVIIa) has demonstrated the ability to improve hemostasis in a variety of disorders; however, there has been a limited

Pretransplant depression, antidepressant
Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation
✍ Shari S. Rogal; Douglas Landsittel; Owen Surman; Raymond T. Chung; Anna Rutherfo πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 176 KB

Depression is a common problem among patients awaiting organ transplantation, but little is known about the impact of depression and its treatment on the outcomes of liver transplantation. In this retrospective cohort analysis, we studied all patients over 18 years of age who underwent liver transpl